MYD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 2.649 EUR -0.97% Market Closed

Market Cap: €238.1m

M	Myriad Genetics Inc XHAM:MYD	US
S	Snam SpA XBER:SNM	IT
A	Adaro Energy Indonesia TBK PT OTC:PADEF	ID
	Primo Brands Corp F:V76	US
C	China Overseas Land & Investment Ltd OTC:CAOVY	HK
	Outlook Therapeutics Inc NASDAQ:OTLK	US

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

68% > 69%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-13%

Operating Margin is Increasing

-26% > -11%

Negative Net Margin

-14%

Negative 3Y Average Net Margin

-31%

Net Margin is Increasing

-36% > -14%

Negative Free Cash Flow Margin

-2%

Negative 3Y Average Free Cash Flow Margin

-10%

Free Cash Flow Margin is Increasing

-17% > -2%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-17% > -16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

68% > 69%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-13%

Operating Margin is Increasing

-26% > -11%